In conjunction with the American Society of Ophthalmic Plastic & Reconstructive Surgery

Date: Saturday, Nov. 16

Time: 8 a.m. to 5:05 p.m.

Location: Morial Convention Center

Schedules

• 2013 Oculofacial Plastic Surgery Subspecialty Day Schedule (PDF 301KB)
• Online Program Search for Subspecialty Day courses and events will be available in June.

Registration and Hotel Reservations

• Registration and hotel reservations for Subspecialty Day meetings and the Annual Meeting opens for Academy members June 26, and nonmembers July 10.

Registration for the Oculofacial Plastic Surgery Subspecialty meeting allows you to:

• Visit the Annual Meeting Exhibit Hall on Saturday, Nov. 16.
• Float among all Subspecialty Day meetings held on Saturday, Nov. 16 – Cornea, Glaucoma, Neuro-Ophthalmology, Oculofacial Plastic Surgery, Pediatric Ophthalmology, Refractive Surgery and Retina.

Oculofacial Plastic Surgery Program

Program Directors
Robert G. Fante, MD, FACS; David B. Lyon, MD, FACS

Program Planning Group
Cat N. Burkat, MD; Sheri L. De Martelaere, MD; Robert G. Fante, MD, FACS; Andrew R. Harrison, MD; Mark J. Lucarelli, MD, FACS; David B. Lyon, MD, FACS; Mark L. Mazow, MD; Randal T. Pham, MD, FACS; Peter J. Sneed, MD; Michael T. Yen, MD

Mission Statement
The mission of the 2013 Oculofacial Plastic Surgery Subspecialty Day is to provide attendees with a comprehensive, state-of-the-art update on treatments in oculofacial plastic surgery. The practice gap was identified by interviews with recognized thought leaders in the field of oculofacial plastic surgery, a review of national data from peer-reviewed published literature and databases, and post-activity surveys from national oculofacial plastic surgery meetings.

Target Audience
The intended audience for this program is practicing oculofacial surgeons.

Education Level
Intermediate, Advanced

Goal
To provide attendees with a comprehensive update on improved patient care and outcomes.

Program Objectives
Upon completion of this activity, participants should be able to:

• Identify and effectively apply modern, evidence-based algorithms in oculofacial plastic surgery disease treatment
• Compare the contemporary management of traumatic, inflammatory, and neoplastic orbital disease using therapies such as biologics, intra-arterial chemotherapy, antibiotics, and surgery
• Evaluate complex orbital and oculoplastics cases to understand treatment outcomes
• Describe the practice patterns of experienced oculofacial practitioners and recognize differences in patient management

CME Accreditation
The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Academy of Ophthalmology designates this live activity for a maximum of 7 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Attendees registered as exhibitors, spouses or guests are not eligible for CME credits.